MEDICOX Co. Ltd
MEDICOX Co., Ltd. operates in the shipbuilding equipment, electric motor, and generator businesses in South Korea and internationally. It produces blocks, such as bows, sterns, propeller bosses, and engine rooms for very large ships; and generators for ship power generation, as well as motors and traction motors. The company is also involved in the provision of customized manufacturing services, … Read more
MEDICOX Co. Ltd (054180) - Total Liabilities
Latest total liabilities as of March 2025: ₩27.34 Billion KRW
Based on the latest financial reports, MEDICOX Co. Ltd (054180) has total liabilities worth ₩27.34 Billion KRW as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MEDICOX Co. Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how MEDICOX Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MEDICOX Co. Ltd Competitors by Total Liabilities
The table below lists competitors of MEDICOX Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IND.VAERDEN -A- (IDVA.SG)
STU:IDVA
|
Germany | €7.75 Billion |
|
Profithol S.A.
MC:SPH
|
Spain | €17.69 Million |
|
SODEXO
MU:SJ7
|
Germany | €11.23 Billion |
|
Quarta-Rad Inc
PINK:QURT
|
USA | $267.76K |
|
PreAxia Health Care Payment Systems Inc
PINK:PAXH
|
USA | $722.96K |
|
FIRSTENERGY
MU:FE7
|
Germany | €37.06 Billion |
|
Aequus Pharmaceuticals Inc
OTCQB:AQSZF
|
USA | $7.09 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down MEDICOX Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.21 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEDICOX Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEDICOX Co. Ltd (2012–2024)
The table below shows the annual total liabilities of MEDICOX Co. Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩28.97 Billion | -15.91% |
| 2023-12-31 | ₩34.46 Billion | -26.99% |
| 2022-12-31 | ₩47.19 Billion | +30.10% |
| 2021-12-31 | ₩36.28 Billion | -22.80% |
| 2020-12-31 | ₩46.99 Billion | +23.71% |
| 2019-12-31 | ₩37.99 Billion | +9.04% |
| 2018-12-31 | ₩34.84 Billion | -2.97% |
| 2017-12-31 | ₩35.90 Billion | -0.72% |
| 2016-12-31 | ₩36.16 Billion | +40.15% |
| 2015-12-31 | ₩25.80 Billion | -4.11% |
| 2014-12-31 | ₩26.91 Billion | -13.15% |
| 2012-12-31 | ₩30.98 Billion | -- |